Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

38.04 +1.09 (+2.95%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CRISPR Therapeutics AG - Common Shares

< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
32 33 Next >
Cathie Wood Buys Roblox, Palantir Dips — Ark Invest Seizes Buying Opportunities Following Earnings Reports
Via Benzinga
The 3 Best Biotech Stocks to Buy in August
Even as healthcare stocks suffer from post-pandemic fatigue, these three of the best biotech stocks to buy and ride the wave of good news. 
Via InvestorPlace
2 Supercharged Growth Stocks That Could Make You Richer
These two biotechs are poised for a sustained period of growth. 
Via The Motley Fool
2 Great Stocks Under $100 to Buy and Hold for 10 Years
Neither has performed well over the past year, but investors would do well to focus on the longer term. 
Via The Motley Fool
Fox, Warner Music, Eli Lilly, Chegg And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Dow Jones falling around 400 points on Tuesday. Here are some big stocks recording gains in today’s session. Paymentus Holdings, Inc. (NYSE: PAY) shares rose 29.4% to... 
Via Benzinga
1 No-Brainer Cathie Wood Stock to Buy Hand Over Fist in August
Crispr Therapeutics could be incredibly undervalued right now. 
Via The Motley Fool
Why Energizer Holdings Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 185.6% to $1.6593 after the company announced contract with NASA to demonstrate feasibility of power beaming in space using the company’s blue laser... 
Via Benzinga
Why CRISPR Therapeutics Stock Is Jumping Today
Analysts continue to like this gene-editing stock. 
Via The Motley Fool
The Latest Analyst Ratings for CRISPR Therapeutics
Via Benzinga
2 Magnificient Growth Stocks to Buy in July
These two growth stocks might be incredibly undervalued right now. 
Via The Motley Fool
3 Biotech Stocks That Analysts Are Drooling Over
With the medical science realm representing one of the most complex markets, these top analyst biotech picks can be worth your time. 
Via InvestorPlace
3 ‘Strong Buy’ Biotech Stocks You Should Be Loading Up On Now
Biotech stocks can be a lucrative investment opportunity, these three biotech stocks to buy now are among analyst favorites. 
Via InvestorPlace
Vertex Pharma Raises Annual Forecast On Strong Uptake For Cystic Fibrosis Drug, Analysts Says Investors' Focus On Non-CF Pipeline
Vertex Pharmaceuticals Inc's (NASDAQ: VRTX) Q2 sales increased 14% to $2.49 billion, beating the consensus of $2.41 bill 
Via Benzinga
3 Hidden Penny Stocks That Could Turn $100 into $10,000
These penny stocks have multibagger upside potential with great margins of safety, according to Wall Street analysts. 
Via InvestorPlace
These 2 Stocks Are Heading for a Big Moment. Time to Buy?
Both stocks have climbed in the double digits this year. 
Via The Motley Fool
This 1 Innovation Could Make These 2 Biotechs Soar by 2030
Simplifying the cell therapy manufacturing process could be worth a lot of money. 
Via The Motley Fool
2 Soaring Stocks With More Upside Potential
Are these mid-cap stocks giants in the making? 
Via The Motley Fool
Is Now a Good Time to Buy CRISPR Therapeutics?
CRISPR shares have climbed more than 40% this year. 
Via The Motley Fool
3 Tech Stocks to Watch for Groundbreaking Innovations in 2030
If you’re a speculative investor here are three companies that are on the leading edge of what may be groundbreaking innovations by 2030. 
Via InvestorPlace
2 Monster Stocks to Buy Without Any Hesitation
These players each bring in billions of dollars in earnings every year. 
Via The Motley Fool
Cathie Wood Is Buying These 3 Growth Stocks Hand Over Fist. Should You?
The captain of innovation-focused investing can't seem to get enough of these beaten-down growth stocks. 
Via The Motley Fool
3 Pharma Stocks That AI is Loving in July
Artificial intelligence recommends that these are the three stocks to consider when investing in pharma stocks. 
Via InvestorPlace
2 No-Brainer Healthcare Stocks to Buy With $100 Right Now
These stocks may not stay this low for long. 
Via The Motley Fool
3 Top Biotech Stocks Defying the Bear Market
Each has the potential to dramatically outperform the market. 
Via The Motley Fool
3 Biotech Stocks to Buy for Long-Term Gains
The biotech sector is one of the most volatile sectors, but here are three biotech stocks that offer opportunities for patient biotech stock investors. 
Via MarketBeat
Topics ETFs Economy
Exposures Interest Rates
3 Things About Vertex Pharmaceuticals That Smart Investors Know
Vertex shares have advanced about 20% so far this year. 
Via The Motley Fool
2 Top Healthcare Stocks Defying the Bear Market
These stocks are rising in the double digits -- and outperforming the S&P 500. 
Via The Motley Fool
Sitting on Cash? These 2 Stocks Are Great Buys
Coca-Cola and Vertex Pharmaceuticals are excellent choices to add to your portfolio for the long term. 
Via The Motley Fool
3 Growth Stocks With 55% to 71% Upside, According to Wall Street
Find out why investment bank analysts are so bullish on these stocks. 
Via The Motley Fool
2 Growth Stocks That Might Be Too Cheap to Ignore
The sky is the limit for these healthcare companies. 
Via The Motley Fool
< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.